Auto Amazon Links: No products found.
A free meningitis B (MenB) vaccine is now being offered to approximately one million young people in England, following a significant outbreak earlier this year in Kent. This outbreak was noted as the largest and fastest growing of its kind in the UK. Since the campaign began, nearly 90,000 doses have already been administered, with an additional 135,000 appointments scheduled for the near future. This vaccination programme targets those starting university or residential further education for the first time this autumn, aiming to provide timely protection against this serious bacterial infection.
The MenB vaccine protects against a particularly harmful strain of meningitis responsible for the Kent outbreak. Importantly, the vaccine does not include any live bacteria and cannot cause the disease itself. Some recipients might experience mild side effects such as tenderness or redness at the injection site, low fever, nausea, headache, or muscle aches, but these symptoms typically resolve within a day or two. Severe reactions are very uncommon, making the vaccine a safe preventive measure.
Those eligible for the vaccine include 17- and 18-year-olds in sixth form as well as individuals under 25 who are about to begin university or residential college studies for the first time. The course requires two doses at least 28 days apart to ensure full effectiveness. Individuals born between 1 September 2007 and 31 August 2008, and those born on or after 21 July 2001 entering higher education or further education residential settings this autumn, qualify to receive the vaccine. Walk-in vaccinations are available at participating high street pharmacies throughout England, and prior registration with a GP is not necessary to use this service.
The urgency of this immunization effort comes in response to the Kent outbreak in March, which saw
Read the full article from The BBC here: Read More
Auto Amazon Links: No products found.